The Ugandan drug make Cipla Quality Chemical Industries Limited has (CQCIL) has raised Shs155 billion (US$41 million) from its initial public offering (IPO) that was oversubscribed, according to a brokerage firm- Renaissance Capital that helped advise on the transaction. CQCIL, majorly owned by India's third-largest drug maker, Cipla, sold 657 million shares equivalent to 18 […]
The post Drug maker CQCIL raises Shs155b in IPO appeared first on Eagle Online.
Source
